Related Experiment Video
Updated: May 23, 2026
07:32
Novel Apparatus and Method for Drug Reinforcement
Published on: August 20, 2010
University-based continuing education for pharmacists.
Theresa J Schindel1, James P Kehrer, Nesé Yuksel
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. tschindel@pharmacy.ualberta.ca
American Journal of Pharmaceutical Education
|March 23, 2012
Summary
University-based continuing education (CE) supports pharmacists' professional development and advances pharmacy practice. Future directions emphasize integrating CE with faculty activities and expanding its reach to meet evolving healthcare needs.
Area of Science:
- Pharmacy education
- Continuing professional development
Background:
- University-based continuing education (CE) is vital for pharmacist professional development and advancing healthcare.
- Expanded pharmacy scope of practice necessitates evolving CE approaches.
Purpose of the Study:
- To discuss the role and future directions of university-based CE in pharmacy.
- To propose strategies for enhancing CE to meet current and future needs of pharmacists.
Main Methods:
- This paper presents a perspective from a Faculty of Pharmacy on future CE directions.
- It discusses integration of CE with core faculty activities and audience expansion.
Main Results:
- Current CE models incorporate diverse approaches, emphasizing the learning process and continuing professional development (CPD).
- Future directions include integrating CE with academic activities, broadening audience, and forming strategic partnerships.
Conclusions:
- University-based CE is crucial for bridging academic and practice environments.
- The Faculty of Pharmacy and Pharmaceutical Sciences advocates for a proactive approach to shaping the future of CE in pharmacy.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:19Nonlinear Pharmacokinetics: Overview
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...